Tuesday, December 5, 2023

FDA plans to test ‘trans’ treatment on children

The Food and Drug Administration (FDA) is reportedly interested in conducting a study of so-called “gender-affirming” drugs on minors as young as 13. A pro-“trans” nonprofit initially proposed testing the regimen on adults, but the Biden administration’s FDA “suggested the company broaden its study to include children,” POLITICO reported.  READ

No comments:

Post a Comment